Strive, Inc. Completes Semler Acquisition, Stock Declines

Written by Emily J. Thompson, Senior Investment Analyst

ASST+4.2%

Source: Benzinga

Updated: Jan 16 2026

0mins

Source: Benzinga

Bitcoin Holdings: Strive currently holds approximately 12,797.9 bitcoins, making it the 11th largest publicly traded corporate holder globally, indicating a strategic positioning in the cryptocurrency sector.
Executive Appointment: Avik Roy has been appointed as Chief Strategy Officer, focusing on monetizing Semler Scientific's operations by expanding into early-disease detection products, aiming to enhance the company's competitiveness in the healthcare industry.
Stock Performance: Strive's stock is trading at $0.96, which is 5.2% above its 20-day simple moving average but 56.4% below its 100-day simple moving average, reflecting a struggle to maintain long-term momentum.
Earnings Expectations: Analysts expect Strive to report an EPS of -$0.01 on March 30, 2026, an improvement from -$0.21 year-over-year, with projected revenue of $1.80 million, indicating potential for future growth.

ASST

$0.8189+Infinity%1D

Analyst Views on ASST

Wall Street analysts forecast ASST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASST is 1.50 USD with a low forecast of 1.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Analyst Rating

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.786

Low

1.50

Averages

1.50

High

1.50

Current: 0.786

Low

1.50

Averages

1.50

High

1.50

Maxim

Buy

initiated

$1.50

2025-12-10

Reason

Maxim

Price Target

$1.50

AI Analysis

2025-12-10

initiated

Buy

Reason

Maxim initiated coverage of Strive with a Buy rating and $1.50 price target. The company stands out in the digital-asset treasury space with scale, a clean balance sheet, a focus on common and perpetual preferred equity for financing, and deep macro experience, the analyst tells investors in a research note. Maxim adds that it expects rapid scaling of BTC assets as capital markets activity expands the balance sheet.

Benchmark

Buy

downgrade

$101 -> $86

2025-09-23

Reason

Benchmark

Price Target

$101 -> $86

2025-09-23

downgrade

Buy

Reason

Benchmark lowered the firm's price target on Semler Scientific (SMLR) to $86 from $101 and keeps a Buy rating on the shares after Semler agreed to be acquired by Strive (ASST) in an all-stock deal. While the market is sorting out the longer-term implications of the transaction, it appears to the firm that Semler shares \"represent an opportunity right now\" and that this deal seems to have \"rung the opening bell for consolidation in the corporate bitcoin treasury space,\" the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ASST

Unlock Now

About ASST

Strive, Inc., formerly Asset Entities Inc., is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is an SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.